Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.40 |
| ▸ | GSK3B | P49841 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | PARP1 | P09874 | 6/20 | 0.37 |
| ▸ | GSK3A | P49840 | 1/20 | 0.36 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.36 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.36 |
| ▸ | CASP3 | P42574 | 6/20 | 0.36 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.34 |
| ▸ | PARP3 | Q9Y6F1 | 1/20 | 0.34 |
| ▸ | CASP7 | P55210 | 3/20 | 0.34 |
| ▸ | CASP6 | P55212 | 2/20 | 0.34 |
| ▸ | CASP8 | Q14790 | 2/20 | 0.34 |
| ▸ | CASP2 | P42575 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 3/20 | 0.33 |
| ▸ | POLB | P06746 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3882337 | 1.00 | KDM4E (0.40) | KDM4EALDH1A1HPGDHSD17B10MAPK10 | |
| SCHEMBL476301 | 1.00 | KDM4E (0.40) | KDM4EALDH1A1HPGDHSD17B10MAPK10 | |
| SCHEMBL30614595 | 1.00 | KDM4E (0.40) | KDM4EALDH1A1HPGDHSD17B10MAPK10 | |
| Methane SCHEMBL28294512 | 0.98 | KDM4E (0.40) | KDM4EALDH1A1HPGDHSD17B10MAPK10 | |
| SCHEMBL25256110 | 0.88 | ALDH1A1 (0.44) | KDM4EALDH1A1HPGDHSD17B10MAPK10 | |
| SCHEMBL25217371 | 0.88 | ALDH1A1 (0.44) | KDM4EALDH1A1HPGDHSD17B10MAPK10 | |
| SCHEMBL25256112 | 0.88 | ALDH1A1 (0.44) | KDM4EALDH1A1HPGDHSD17B10MAPK10 | |
| SCHEMBL30352814 | 0.88 | ALDH1A1 (0.44) | KDM4EALDH1A1HPGDHSD17B10MAPK10 | |
| SCHEMBL27815646 | 0.85 | KDM4E (0.39) | KDM4EALDH1A1HPGDHSD17B10MAPK10 | |
| SCHEMBL4716290 | 0.83 | KDM4E (0.41) | KDM4EALDH1A1HPGDHSD17B10MAPK10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110885325-B | Preparation method of (S) -glycidol phthalimide | 新发药业有限公司 | 2021-09-07 | — | — | CN | claimed |
| US-RE47606-E1 | Process for the preparation of linezolid | OPTIMUS DRUGS PRIVATE LIMITED (IN) | 2019-09-17 | — | — | US | claimed |
| EP-3250568-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF LINEZOLID | Optimus Drugs Pvt Ltd (IN) | 2017-12-06 | — | — | EP | claimed |
| WO-2017182853-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF LINEZOLID | OPTIMUS DRUGS PVT LTD (IN) | 2017-10-26 | — | — | WO | claimed |
| US-9643939-B1 | Process for the preparation of linezolid | OPTIMUS DRUGS PRIVATE LIMITED (US) | 2017-05-09 | — | — | US | claimed |
| US-9593104-B2 | Process for the preparation of oxazolidinone derivatives | BENOVA LABS PVT. LIMITED (IN) | 2017-03-14 | — | — | US | claimed |
| US-20160039803-A1 | PROCESS FOR THE PREPARATION OF OXAZOLIDINONE DERIVATIVES | BENOVA LABS PVT. LIMITED (IN) | 2016-02-11 | — | — | US | claimed |
| WO-2014141067-A2 | PROCESS FOR THE PREPARATION OF OXAZOLIDINONE DERIVATIVES | BENOVA LABS PVT LIMITED (IN) | 2014-09-18 | — | — | WO | claimed |
| US-8637667-B2 | Method for preparing (S)-5-chloro-N-((3-(4-(5,6-dihydro-4H-1,2,4-oxadiazin-3-yl)phenyl)-2-oxooxazolidin-5-yl)methyl)thiophene-2-carboxamide derivatives | LEGOCHEM BIOSCIENCE LTD. (KR) | 2014-01-28 | — | — | US | claimed |
| US-20120108808-A1 | METHOD FOR PREPARING (S)-5-CHLORO-N-((3-(4-(5,6-DIHYDRO-4H-1,2,4-OXADIAZIN-3-YL)PHENYL)-2-OXOOXAZOLIDIN-5-YL)METHYL)THIOPHENE-2-CARBOXAMIDE DERIVATIVES | LEGOCHEM BIOSCIENCE LTD. (KR) | 2012-05-03 | — | — | US | claimed |
| US-12503452-B2 | Antimicrobial compounds and methods | CURZA GLOBAL, LLC (US) | 2025-12-23 | — | — | US | disclosed |
| US-20230159491-A1 | Antimicrobial Compounds and Methods | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2023-05-25 | — | — | US | disclosed |
| CN-113924292-A | Antimicrobial compounds and methods | 库扎环球有限责任公司 | 2022-01-11 | — | — | CN | disclosed |
| EP-3911644-A1 | ANTIMICROBIAL COMPOUNDS AND METHODS | Curza Global LLC (US) | 2021-11-24 | — | — | EP | disclosed |
| CN-110885325-B | Preparation method of (S) -glycidol phthalimide | 新发药业有限公司 | 2021-09-07 | — | — | CN | disclosed |
| EP-1564215-A1 | Process for preparing glycidylphthalimide | DAISO CO., LTD. (JP) | 2005-08-17 | — | — | EP | disclosed |
| US-20050113583-A1 | Process for preparing glycidylphthalimide | OSAKA SODA CO., LTD. (JP) | 2005-05-26 | — | — | US | disclosed |
| US-6875875-B2 | Process for preparing glycidylphthalimide | DAISO CO., LTD. (JP) | 2005-04-05 | — | — | US | disclosed |
| US-20040087802-A1 | Process for preparing glycidylphthalimide | OSAKA SODA CO., LTD. (JP) | 2004-05-06 | — | — | US | disclosed |
| EP-1403267-A1 | Process for preparing glycidylphthalimide | DAISO CO., LTD. (JP) | 2004-03-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230159491-A1 | Antimicrobial Compounds and Methods | MPO, NISCH, RPN2 | KDM4E 3027/4885ALDH1A1 3752/4885HPGD 1474/4885 |
| US-20050113583-A1 | Process for preparing glycidylphthalimide | EZH1, ALKBH3, PHF2 | KDM4E 694/4885ALDH1A1 1435/4885HPGD 1441/4885 |
| US-20160039803-A1 | PROCESS FOR THE PREPARATION OF OXAZOLIDINONE DERIVATIVES | OXA1L, PPOX, AZI2 | KDM4E 118/4885ALDH1A1 1330/4885HPGD 1284/4885 |
| US-20040087802-A1 | Process for preparing glycidylphthalimide | EZH1, ALKBH3, PHF2 | KDM4E 694/4885ALDH1A1 1435/4885HPGD 1441/4885 |
| US-20120108808-A1 | METHOD FOR PREPARING (S)-5-CHLORO-N-((3-(4-(5,6-DIHYDRO-4H-1,2,4-OXADIAZIN-3-YL)PHENYL)-2-OXOOXAZOLIDIN-5-YL)METHYL)THIOPHENE-2-CARBOXAMIDE DERIVATIVES | F2, F11, F5 | KDM4E 112/4885ALDH1A1 1161/4885HPGD 565/4885 |
| US-12503452-B2 | Antimicrobial compounds and methods | MPO, NISCH, RPN2 | KDM4E 3027/4885ALDH1A1 3752/4885HPGD 1474/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.